DALE G ANDO Insider Trading $SGMO SANGAMO THERAPEUTICS, INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DALE G ANDO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DALE G ANDO. DALE G ANDO is VP, Therapeutic Dev. & CMO in SANGAMO BIOSCIENCES INC ($SGMO).
DALE G ANDO in SANGAMO THERAPEUTICS, INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DALE G ANDO: VP, Therapeutic Dev. & CMO
Holdings: 95,376 shares
Current Value: $367,198
Latest Transaction: Feb 06 2015
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DALE G ANDO in SANGAMO THERAPEUTICS, INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 3,202 | 11,047 | 110,798 | |
| Feb 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 6.82 | 11,798 | 80,462 | 0 | |
| Feb 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 12.93 | 15,000 | 193,950 | 95,376 | 110.4 K to 95.4 K (-13.59 %) |
| Feb 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 3,202 | 11,047 | 110,376 | 107.2 K to 110.4 K (+2.99 %) |
| Feb 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 6.82 | 11,798 | 80,462 | 107,174 | 95.4 K to 107.2 K (+12.37 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 6.82 | 1,500 | 10,230 | 11,798 | |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 15.66 | 600 | 9,394 | 95,376 | 96 K to 95.4 K (-0.63 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 15.17 | 14,400 | 218,460 | 95,976 | 110.4 K to 96 K (-13.05 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 6.82 | 15,000 | 102,300 | 110,376 | 95.4 K to 110.4 K (+15.73 %) |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 4.11 | 13,202 | 54,260 | 36,798 | |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 12.98 | 1,798 | 23,339 | 96,579 | 98.4 K to 96.6 K (-1.83 %) |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 12.99 | 13,202 | 171,507 | 98,377 | 111.6 K to 98.4 K (-11.83 %) |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 4.11 | 13,202 | 54,260 | 111,579 | 98.4 K to 111.6 K (+13.42 %) |
| May 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 0 | |
| May 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 13,000 | 44,850 | 114,000 | |
| May 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 13.57 | 2,000 | 27,134 | 98,377 | 100.4 K to 98.4 K (-1.99 %) |
| May 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 100,377 | 98.4 K to 100.4 K (+2.03 %) |
| May 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 13.57 | 13,000 | 176,397 | 98,377 | 111.4 K to 98.4 K (-11.67 %) |
| May 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 13,000 | 44,850 | 111,377 | 98.4 K to 111.4 K (+13.21 %) |
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 2,000 | |
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 13,000 | 44,850 | 127,000 | |
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | S | 13.63 | 2,000 | 27,255 | 97,015 | 95 K to 97 K (+2.10 %) |
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 99,015 | 97 K to 99 K (+2.06 %) |
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | S | 13.64 | 13,000 | 177,277 | 97,015 | 84 K to 97 K (+15.47 %) |
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 13,000 | 44,850 | 110,015 | 97 K to 110 K (+13.40 %) |
| Mar 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 4,000 | |
| Mar 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 13,000 | 44,850 | 140,000 | |
| Mar 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 18.64 | 2,000 | 37,283 | 97,015 | 99 K to 97 K (-2.02 %) |
| Mar 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 99,015 | 97 K to 99 K (+2.06 %) |
| Mar 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 19.10 | 200 | 3,820 | 97,015 | 97.2 K to 97 K (-0.21 %) |
| Mar 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 18.64 | 12,800 | 238,592 | 97,215 | 110 K to 97.2 K (-11.63 %) |
| Mar 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 13,000 | 44,850 | 110,015 | 97 K to 110 K (+13.40 %) |
| Feb 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 6,000 | |
| Feb 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 13,000 | 44,850 | 153,000 | |
| Feb 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 19.73 | 2,000 | 39,452 | 97,015 | 99 K to 97 K (-2.02 %) |
| Feb 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 99,015 | 97 K to 99 K (+2.06 %) |
| Feb 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 19.72 | 13,000 | 256,300 | 97,015 | 110 K to 97 K (-11.82 %) |
| Feb 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 13,000 | 44,850 | 110,015 | 97 K to 110 K (+13.40 %) |
| Jan 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 8,000 | |
| Jan 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 13,000 | 44,850 | 166,000 | |
| Jan 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 18.73 | 2,000 | 37,455 | 97,015 | 99 K to 97 K (-2.02 %) |
| Jan 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 99,015 | 97 K to 99 K (+2.06 %) |
| Jan 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 18.56 | 13,000 | 241,275 | 97,015 | 110 K to 97 K (-11.82 %) |
| Jan 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 13,000 | 44,850 | 110,015 | 97 K to 110 K (+13.40 %) |
| Dec 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 10,000 | |
| Dec 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 13,000 | 44,850 | 179,000 | |
| Dec 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 14.22 | 2,000 | 28,446 | 97,015 | 99 K to 97 K (-2.02 %) |
| Dec 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 99,015 | 97 K to 99 K (+2.06 %) |
| Dec 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 14.39 | 13,000 | 187,031 | 97,015 | 110 K to 97 K (-11.82 %) |
| Dec 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 13,000 | 44,850 | 110,015 | 97 K to 110 K (+13.40 %) |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | A | 12.12 | 46,000 | 557,520 | 46,000 | |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Payment of Exercise | F | 12.12 | 14,783 | 179,170 | 97,015 | 111.8 K to 97 K (-13.22 %) |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Grant | A | 0.00 | 23,000 | 0 | 111,798 | 88.8 K to 111.8 K (+25.90 %) |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 3,000 | 15,570 | 12,000 | |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 2,000 | 6,900 | 192,000 | |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 10,000 | 36,100 | 0 | |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 11.83 | 3,000 | 35,476 | 88,798 | 91.8 K to 88.8 K (-3.27 %) |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 3,000 | 15,570 | 91,798 | 88.8 K to 91.8 K (+3.38 %) |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 11.83 | 12,000 | 141,902 | 88,798 | 100.8 K to 88.8 K (-11.90 %) |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 2,000 | 6,900 | 100,798 | 98.8 K to 100.8 K (+2.02 %) |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 10,000 | 36,100 | 98,798 | 88.8 K to 98.8 K (+11.26 %) |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 3,000 | 15,570 | 15,000 | |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 2,000 | 6,900 | 194,000 | |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 10,000 | 36,100 | 10,000 | |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.39 | 3,000 | 31,156 | 86,798 | 89.8 K to 86.8 K (-3.34 %) |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 3,000 | 15,570 | 89,798 | 86.8 K to 89.8 K (+3.46 %) |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.39 | 12,000 | 124,624 | 86,798 | 98.8 K to 86.8 K (-12.15 %) |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 2,000 | 6,900 | 98,798 | 96.8 K to 98.8 K (+2.07 %) |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 10,000 | 36,100 | 96,798 | 86.8 K to 96.8 K (+11.52 %) |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 3,000 | 15,570 | 18,000 | |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 2,000 | 6,900 | 196,000 | |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 10,000 | 36,100 | 20,000 | |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.56 | 3,000 | 31,684 | 84,798 | 87.8 K to 84.8 K (-3.42 %) |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 3,000 | 15,570 | 87,798 | 84.8 K to 87.8 K (+3.54 %) |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.57 | 12,000 | 126,890 | 84,798 | 96.8 K to 84.8 K (-12.40 %) |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 2,000 | 6,900 | 96,798 | 94.8 K to 96.8 K (+2.11 %) |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 10,000 | 36,100 | 94,798 | 84.8 K to 94.8 K (+11.79 %) |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 21,000 | |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 1,000 | 3,450 | 198,000 | |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 10,000 | 36,100 | 30,000 | |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.04 | 2,000 | 20,077 | 84,798 | 86.8 K to 84.8 K (-2.30 %) |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.04 | 2,000 | 20,077 | 86,798 | 88.8 K to 86.8 K (-2.25 %) |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 88,798 | 86.8 K to 88.8 K (+2.30 %) |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.04 | 11,000 | 110,453 | 86,798 | 97.8 K to 86.8 K (-11.25 %) |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 1,000 | 3,450 | 97,798 | 96.8 K to 97.8 K (+1.03 %) |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 10,000 | 36,100 | 96,798 | 86.8 K to 96.8 K (+11.52 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 23,000 | |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 1,000 | 3,450 | 199,000 | |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 10,000 | 36,100 | 40,000 | |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.12 | 2,000 | 20,242 | 86,798 | 88.8 K to 86.8 K (-2.25 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.12 | 2,000 | 20,239 | 88,798 | 90.8 K to 88.8 K (-2.20 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 90,798 | 88.8 K to 90.8 K (+2.25 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.08 | 11,000 | 110,827 | 88,798 | 99.8 K to 88.8 K (-11.02 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 1,000 | 3,450 | 99,798 | 98.8 K to 99.8 K (+1.01 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 10,000 | 36,100 | 98,798 | 88.8 K to 98.8 K (+11.26 %) |
| May 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 50,000 | |
| May 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 8.32 | 15,000 | 124,818 | 88,798 | 103.8 K to 88.8 K (-14.45 %) |
| May 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 103,798 | 88.8 K to 103.8 K (+16.89 %) |
| Apr 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 65,000 | |
| Apr 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.72 | 15,000 | 160,746 | 88,798 | 103.8 K to 88.8 K (-14.45 %) |
| Apr 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 103,798 | 88.8 K to 103.8 K (+16.89 %) |
| Mar 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 9,200 | 33,212 | 80,000 | |
| Mar 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 5,800 | 20,938 | 0 | |
| Mar 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 9.18 | 15,000 | 137,724 | 88,798 | 103.8 K to 88.8 K (-14.45 %) |
| Mar 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 9,200 | 33,212 | 103,798 | 94.6 K to 103.8 K (+9.73 %) |
| Mar 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 5,800 | 20,938 | 94,598 | 88.8 K to 94.6 K (+6.53 %) |
| Feb 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 5,800 | |
| Feb 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 8.64 | 15,000 | 129,600 | 88,798 | 103.8 K to 88.8 K (-14.45 %) |
| Feb 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 103,798 | 88.8 K to 103.8 K (+16.89 %) |
| Jan 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 20,800 | |
| Jan 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 9.68 | 15,000 | 145,158 | 88,798 | 103.8 K to 88.8 K (-14.45 %) |
| Jan 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 103,798 | 88.8 K to 103.8 K (+16.89 %) |
| Dec 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 35,800 | |
| Dec 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.92 | 15,000 | 88,830 | 88,798 | 103.8 K to 88.8 K (-14.45 %) |
| Dec 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 103,798 | 88.8 K to 103.8 K (+16.89 %) |
| Dec 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.94 | 2,000 | 11,888 | 88,798 | 90.8 K to 88.8 K (-2.20 %) |
| Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | A | 5.41 | 70,000 | 378,700 | 70,000 | |
| Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Grant | A | 0.00 | 35,000 | 0 | 90,798 | 55.8 K to 90.8 K (+62.73 %) |
| Nov 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 50,800 | |
| Nov 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.60 | 15,000 | 84,000 | 55,798 | 70.8 K to 55.8 K (-21.19 %) |
| Nov 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 70,798 | 55.8 K to 70.8 K (+26.88 %) |
| Nov 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.33 | 4,736 | 25,232 | 55,798 | 60.5 K to 55.8 K (-7.82 %) |
| Oct 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 65,800 | |
| Oct 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.72 | 5,000 | 28,600 | 58,534 | 63.5 K to 58.5 K (-7.87 %) |
| Oct 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.69 | 15,000 | 85,335 | 63,534 | 78.5 K to 63.5 K (-19.10 %) |
| Oct 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | M | 3.61 | 15,000 | 54,150 | 78,534 | 93.5 K to 78.5 K (-16.04 %) |
| Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.62 | 1,500 | 8,430 | 63,534 | 65 K to 63.5 K (-2.31 %) |
| Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.62 | 1,500 | 8,435 | 65,034 | 66.5 K to 65 K (-2.25 %) |
| Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.69 | 300 | 1,708 | 66,534 | 66.8 K to 66.5 K (-0.45 %) |
| Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.69 | 500 | 2,847 | 66,834 | 67.3 K to 66.8 K (-0.74 %) |
| Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.70 | 186 | 1,060 | 67,334 | 67.5 K to 67.3 K (-0.28 %) |
| Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.71 | 14 | 80 | 67,520 | 67.5 K to 67.5 K (-0.02 %) |
| Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.72 | 1,000 | 5,723 | 67,534 | 68.5 K to 67.5 K (-1.46 %) |
| Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 80,800 | |
| Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.60 | 15,000 | 84,000 | 68,534 | 83.5 K to 68.5 K (-17.96 %) |
| Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 83,534 | 68.5 K to 83.5 K (+21.89 %) |
| Aug 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.23 | 250 | 1,308 | 68,534 | 68.8 K to 68.5 K (-0.36 %) |
| Aug 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.22 | 200 | 1,044 | 68,784 | 69 K to 68.8 K (-0.29 %) |
| Aug 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.22 | 1,000 | 5,216 | 68,984 | 70 K to 69 K (-1.43 %) |
| Aug 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.21 | 550 | 2,866 | 69,984 | 70.5 K to 70 K (-0.78 %) |
| Aug 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.17 | 200 | 1,034 | 70,534 | 70.7 K to 70.5 K (-0.28 %) |
| Aug 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.16 | 1,630 | 8,411 | 70,734 | 72.4 K to 70.7 K (-2.25 %) |
| Aug 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.15 | 1,170 | 6,026 | 72,364 | 73.5 K to 72.4 K (-1.59 %) |
| Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 95,800 | |
| Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.60 | 15,000 | 84,000 | 73,534 | 88.5 K to 73.5 K (-16.94 %) |
| Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 88,534 | 73.5 K to 88.5 K (+20.40 %) |
| Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 4.99 | 500 | 2,495 | 73,534 | 74 K to 73.5 K (-0.68 %) |
| Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.02 | 500 | 2,510 | 74,034 | 74.5 K to 74 K (-0.67 %) |
| Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.04 | 1,500 | 7,560 | 74,534 | 76 K to 74.5 K (-1.97 %) |
| Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.09 | 1,500 | 7,635 | 76,034 | 77.5 K to 76 K (-1.93 %) |